OGN: Organon & Co. Stock

SIC 2834 – Pharmaceutical Preparations

Valuation
Market Cap ($M) 8,824.04
Enterprise Value ($M) 17,224.04
Book Value ($M) -1,250.00
Book Value / Share -4.93
Price / Book -7.06
NCAV ($M) -8,128.00
NCAV / Share -32.05
Price / NCAV -1.09

Profitability (mra)
Return on Invested Capital (ROIC) 0.16
Return on Assets (ROA) 0.13
Return on Equity (ROE) 0.28

Liquidity (mrq)
Quick Ratio 1.20
Current Ratio 1.61

Balance Sheet (mrq) ($M)
Current Assets 3,719.00
Assets 10,597.00
Liabilities 11,847.00
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 6,304.00
Operating Income 2,035.00
Net Income 1,351.00

Cash Flow Statement (mra) ($M)
Cash From Operations 2,458.00
Cash from Investing -481.00
Cash from Financing -1,333.00

(click for more detail)

File Date Form Activist 13D/G Investors Ownership
(%)
Change
(%)
02-10 13G/A Vanguard Group Inc 11.35 -0.48
02-04 13G BlackRock Inc. 6.70

Top 13F Investors Shares
(1000)
Change
(%)
Value
($1000)
Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)

File Date Form SEC Filings
2022-05-06 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2022 ☐ TRANSITION REPORT P
2022-03-21 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-K
2021-11-12 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2021 ☐ TRANSITION REPO
2021-08-16 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2022-06-28 85,907 654,084 13.13
2022-06-27 101,623 726,493 13.99
2022-06-24 151,828 1,053,082 14.42
2022-06-23 270,847 1,270,971 21.31

(click for more detail)

(click for list of largest short owners)

Similar Companies
NUVB – Nuvation Bio Inc NVO – Novo-Nordisk A/S
NVS – Novartis AG PBH – Prestige Brands Holdings, Inc.
PFE – Pfizer Inc.


Financial data and stock pages provided by
Fintel.io